| Drug Name |
Frovatriptan succinate |
| Drug ID |
BADD_D00977 |
| Description |
Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. |
| Indications and Usage |
For the acute treatment of migraine attacks with or without aura in adults. |
| Marketing Status |
approved; investigational |
| ATC Code |
N02CC07 |
| DrugBank ID |
DB00998
|
| KEGG ID |
D04264
|
| MeSH ID |
C108128
|
| PubChem ID |
152943
|
| TTD Drug ID |
D06FPQ
|
| NDC Product Code |
68462-694; 0603-3718; 66039-865; 50742-299; 69238-1539; 82245-0110; 68625-025; 76055-0008; 63481-025 |
| UNII |
D28J6W18HY
|
| Synonyms |
frovatriptan | 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole | Frova | VML-251 | VML251 | Frovelan | SB 209509 | Allegro | frovatriptan succinate | (+)-(R)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate |
